Benzinga | Jul 27, 2021 11:13AM EDT

Repligen Q2 EPS $0.79 Beats $0.52 Estimate, Sales $163.00M Beat $144.10M Estimate

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.52 by 51.92 percent. This is a 88.1 percent increase over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $163.00 million which beat the analyst consensus estimate of $144.10 million by 13.12 percent. This is a 86.29 percent increase over sales of $87.50 million the same period last year.